Alira Health a leading international healthcare and life sciences advisory firm, announced that it has acquired Wellmera, a healthcare consulting firm headquartered in Basel, Switzerland specializing in market access for the pharmaceutical and biotechnology industries. The acquisition will bring global expertise in market access, pricing and reimbursement, health economics, and real-world evidence to Alira Health’s suite of healthcare advisory services.
The collective organization will advance Alira Health’s mission of enabling healthcare transformation by supporting clients across their product and corporate lifecycles, with services in product development, regulatory, clinical, strategic consulting, and transaction advisory. The Wellmera team brings a wealth of experience in helping clients develop evidence, devise pricing and market access approaches, and provide tailored strategies to local client affiliates in preparation for pricing and reimbursement negotiations around the world, with a focus on European markets.
“We are thrilled to welcome Wellmera and their incredible team to Alira Health. This acquisition is an important step in achieving our vision of offering a full continuum of services, particularly in the critical areas of regulatory, clinical and market access,” said Gabriele Brambilla, CEO of Alira Health, “These expanded services will help us to deliver even greater value to our clients as they develop and bring to market the next generation of healthcare innovations.”
“The Wellmera team is excited to join Alira Health,” says Jean-François Ricci, PharmD PhD, President and Principal at Wellmera. “This partnership allows us to bring our market access expertise to a larger global organization, helping us to impact patient care on an even greater scale. We see many synergies with Alira Health’s lifecycle approach, and a feel a strong connection in our passion for healthcare, our quality of work, and the culture of our teams.”
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Jean-François Ricci will become Executive Vice President of Market Access and will lead Alira Health’s Market Access practice, covering pharma, biotech, and digital health in Europe and the United States.
Source: PR Newswire
